TY  - JOUR
AU  - Cuypers, Lize
AU  - Perez, Ana Belen
AU  - Chueca, Natalia
AU  - Aldamiz-Echevarria, Teresa
AU  - Alados, Juan Carlos
AU  - Martinez-Sapiña, Ana Maria
AU  - Merino, Dolores
AU  - Pineda, Juan Antonio
AU  - Tellez, Francisco
AU  - Espinosa, Nuria
AU  - Salmeron, Javier
AU  - Rivero-Juarez, Antonio
AU  - Vivancos, Maria Jesus
AU  - Hontañon, Víctor
AU  - Vandamme, Anne-Mieke
AU  - Garcia, Federico
PY  - 2018
DO  - 10.1371/journal.pone.0201268
UR  - http://hdl.handle.net/10668/12754
T2  - PloS one
AB  - Despite high response rates associated to hepatitis C virus (HCV) treatment, no protective immunity is acquired, allowing for reinfection and continued infectiousness. Distinguishing between relapse and reinfection is crucial for patient counselling...
LA  - en
PB  - Public Library of Science
KW  - Antiviral Agents
KW  - Coinfection
KW  - Genome, Viral
KW  - HIV Infections
KW  - Hepatitis C
KW  - Hepatitis C, Chronic
KW  - Homosexuality, Male
KW  - Humans
KW  - Male
KW  - Phylogeny
KW  - Recurrence
TI  - Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.
TY  - research article
VL  - 13
ER  -